About 300mcg Filgrastim Injection
Highlighted for its splendid quality and brilliant results, the 300mcg Filgrastim Injection (NISCARINE) by Intas offers highly recommended support for patients facing neutropenia, particularly in oncology. With its pre-filled syringe format and highly polished administration using a subcutaneous route, it ensures precise and comfortable delivery. The best price for this clear, colorless, odorless solution makes it an excellent choice for healthcare providers. Its enzymatic activity boosts neutrophil production, making it essential for hospital use. Delivered securely in a box pack, it guarantees both efficacy and reliability.
Essential Application and Superior Features
The surface of application for the 300mcg Filgrastim Injection is subcutaneous, making it ideal for use by medical professionals in hospital settings. Used predominantly by oncology patients suffering from neutropenia, it stands out for its pre-filled syringe with an attached needle, ensuring safety and convenience. The brilliant clarity and colorless texture, combined with an odorless presentation, reflect its polished pharmaceutical quality and secure handling for practitioners.
Sample Policy, Certifications, and FOB Port - Seamless Supply Chain
Stock-ready and available for immediate shipment, 300mcg Filgrastim Injection adheres to all recommended certifications and hospital supply standards. Delivered efficiently to ensure timely arrival, these injections are dispatched from prominent FOB ports in India. We provide transparent sample policies, supporting direct evaluation by healthcare providers prior to bulk procurement. This commitment ensures that every unit delivered maintains its splendid quality and reliability upon arrival.
FAQ's of 300mcg Filgrastim Injection:
Q: How should the 300mcg Filgrastim Injection be administered?
A: This injection is to be administered subcutaneously by a healthcare professional, ensuring controlled and safe delivery suitable for oncology settings.
Q: What is the main benefit of using Filgrastim 300mcg in oncology?
A: The primary benefit is to stimulate neutrophil production, helping to prevent or manage neutropenia in patients undergoing cancer treatments.
Q: Where is this product typically used and by whom?
A: The 300mcg Filgrastim Injection is mainly used in hospitals and healthcare facilities, administered by trained medical staff to oncology patients.
Q: What makes the NISCARINE injection highly recommended for neutropenia?
A: Its pre-filled syringe format with an attached needle offers precise dosing and ease of use, minimizing preparation errors and enhancing patient safety.
Q: What storage instructions are required for maintaining its efficacy?
A: The injection should be stored at 2-8C, avoiding freezing, to preserve its enzymatic activity and shelf life as indicated on the packaging.